Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zoulim

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Journal of Medical Virology|January 1, 1991
Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infectionsI Chemin, I Baginski, M A Petit, et al.
Journal of Hepatology|October 6, 2000
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severityC Grandjacques, P Pradat, L Stuyver, et al.
Vaccine|June 25, 2011
Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patientsL Cotte, N Voirin, C Richard, et al.
Journal of Clinical Microbiology|February 3, 2000
Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapyL Stuyver, C Van Geyt, S De Gendt, et al.
Journal of Gastroenterology and Hepatology|January 22, 2003
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategiesF Zoulim, P Berthillon, F L E Guerhier, et al.
Journal of Hepatology|January 1, 1993
Simultaneous steroids/interferon therapy in chronic hepatitis BX Causse, H Godinot, M Chevallier, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoF Zoulim, E Dannaoui, C Borel, et al.
Journal of Viral Hepatitis|June 16, 2015
T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patientsQ Wang, P Sachse, M Semmo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2018
Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemiaP Miailhes, K Hartig-Lavie, V Virlogeux, et al.
Journal of Viral Hepatitis|March 12, 2014
Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease scoreV Virlogeux, P Pradat, F Bailly, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Journal of Medical Virology|January 1, 1991
Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infectionsI Chemin, I Baginski, M A Petit, et al.
Journal of Hepatology|October 6, 2000
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severityC Grandjacques, P Pradat, L Stuyver, et al.
Vaccine|June 25, 2011
Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patientsL Cotte, N Voirin, C Richard, et al.
Journal of Clinical Microbiology|February 3, 2000
Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapyL Stuyver, C Van Geyt, S De Gendt, et al.
Journal of Gastroenterology and Hepatology|January 22, 2003
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategiesF Zoulim, P Berthillon, F L E Guerhier, et al.
Journal of Hepatology|January 1, 1993
Simultaneous steroids/interferon therapy in chronic hepatitis BX Causse, H Godinot, M Chevallier, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoF Zoulim, E Dannaoui, C Borel, et al.
Journal of Viral Hepatitis|June 16, 2015
T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patientsQ Wang, P Sachse, M Semmo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2018
Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemiaP Miailhes, K Hartig-Lavie, V Virlogeux, et al.
Journal of Viral Hepatitis|March 12, 2014
Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease scoreV Virlogeux, P Pradat, F Bailly, et al.
Pageof 13